Librea, Vevencio .
HRN: 23-23-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
MEBENDAZOLE 500MG (TAB)
07/03/2023
07/03/2023
PO
500mg
OD
T/C Parasitic Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes